Blog - INTERNET MÉDICA

■ Diabetic retinopathy screening and monitoring of early stage disease in Australian general practice: tackling preventable blindness within a chronic care model

Lisa Crossland, Deborah Askew, Robert Ware, Peter Cranstoun, Paul Mitchell, Andrew Bryett, Claire Jackson

J Diabetes Res. 2016; 2016: 8405395

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698989/

■ Diabetic retinopathy screening using telemedicine tools: pilot study in Hungary

Dóra J. Eszes, Dóra J. Szabó, Greg Russell et al

J Diabetes Res. 2016; 2016: 4529824

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204085/

■ The role of dyslipidemia control in the progression of diabetic retinopathy in patients with type 2 diabetes mellitus

Irini P. Chatziralli

Diabetes Ther. 2017 Apr; 8(2): 209–212

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380502/

■ Treatment strategies for chorioretinal vascular diseases: advantages and disabantages of individualized therapy

M W Stewart

EMJ Diabet 2016, vol 4 (1): 91-98

http://emjreviews.com/wp-content/uploads/Treatment-Strategies-for-Chorioretinal-Vascular-Diseases-Advantages-and-Disadvantages-of-Individualised-Therapy.pdf

■ Fatores de risco e incidência da retinopatia diabética.

Mendanha, Denise Borges de Andrade et al.

Rev. bras.oftalmol., Dez 2016, vol.75, no.6, p.443-446

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802016000600443&lng=en&nrm=iso

■ Noninvasive retinal markers in diabetic retinopathy: advancing frombench towards bedsid

Søren Leer Blindbæk, Thomas Lee Torp, Kristian Lundberg et al

J Diabetes Res. 2017; 2017: 2562759.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406729/

■ The evaluation of ocular changes in prediabetic individuals

A Sokolowska-Oracz, P Piatkiewicz

Clinical Diabetology 2017, vol 6 (1): 8-16

https://journals.viamedica.pl/clinical_diabetology/article/view/DK.2017.0003/40758

■ Overview of ocular anti-vascular endothelial growth factor therapy in the management of diabetic eye complications

Oluwaranti Akiyode, Christine Tran

Diabetes Spectr. 2016 Feb; 29(1): 44–49

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755448/

■ Prevalence of undiagnosed diabetic retinopathy among inpatients with diabetes: the diabetic retinopathy inpatient study (DRIPS)

Jessica J Kovarik, Andrew W Eller, Lauren A Willard et al

BMJ Open Diabetes Res Care. 2016; 4(1): e000164

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761984/

■ Problem-solving therapy for adults with diabetic retinopathy and diabetes-specific distress: a pilot randomized controlled trial

Gwyneth Rees, Fleur O’Hare, Marian Saeed et al

BMJ Open Diabetes Res Care. 2017; 5(1): e000307

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304260/

■ Inpatient screening for albuminuria and retinopathy to p´redict long-term mortality in type 2 diabetic patients: a retrospective cohort study

Ya-Mei Hsieh, Wen-Jane Lee, Wayne H.-H. Sheu et al

Diabetol Metab Syndr. 2017; 9: 29

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415718/

■ Visual acuity, retinal sensitivity, and macular thickness changes in diabetic patients withou diabetic retinopathy after cataract surgery

Spela Stunf Pukl, Nataša Vidović Valentinčič, Mojca Urbančič et al

J Diabetes Res. 2017; 2017: 3459156

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294376/

■ Danish nationwide data reveal a link between diabetes mellitus diabetic retinopathy, and glaucoma

Anna Horwitz, Beáta Éva Petrovski, Christian Torp-Pedersen, Miriam Kolko

J Diabetes Res. 2016; 2016: 2684674

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107855/

■ Lower hemoglobin concentration is associated with retinal ischemia and the severity of diabetic retinopathy in type 2 diabetes

Alicia Traveset, Esther Rubinat, Emilio Ortega et AL

J Diabetes Res. 2016; 2016: 3674946

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855016/

■ Bariatric surgery and diabetic retinopathy: a systematic review and meta-analysis of controlled clinical studies

C Merlotti, V Ceriani, A Morabito and A Pontiroli

Obesity Review 2017, vol 18 (3): 309-316

http://onlinelibrary.wiley.com/doi/10.1111/obr.12490/full

■ Diabetic retinopathy in Italy: epidemiology data and telemedicine screening programs

Stela Vujosevic, Edoardo Midena

J Diabetes Res. 2016; 2016: 3627465

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136623/

■ The adenosinergic system in diabetic retinopathy

Vindeirinho, A. R. Santiago, C. Cavadas, A. F. Ambrósio, P. F. Santos

J Diabetes Res. 2016; 2016: 4270301.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789509/

■ Circulating biomarkers of diabetic retinopathy: an overview based on physiopathology

Olga Simó-Servat, Rafael Simó, Cristina Hernández

J Diabetes Res. 2016; 2016: 5263798

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916280/

■ Neuroprotection as a therapeutic target for diabetic retinopathy

Cristina Hernández, Massimo Dal Monte, Rafael Simó, Giovanni Casini

J Diabetes Res. 2016; 2016: 9508541

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830713/

■ Incretin-based therapy for prevention of diabetic vascular complications

Akira Mima

J Diabetes Res. 2016; 2016: 1379274

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735992/

■ Diabetic macular edema pathophysiology: vasogenic versus inflammatory

Pedro Romero-Aroca, Marc Baget-Bernaldiz, Alicia Pareja-Rios et al

J Diabetes Res. 2016; 2016: 2156273

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059543/

■ Influence of age at diagnosis and time-dependent risk factors on the development of diabetic retinopathy in patient with type 1 diabetes

Luis Forga, María José Goñi, Berta Ibáñez et AL

J Diabetes Res. 2016; 2016: 9898309

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861784/

■ Evaluation of cytokines in type 1 diabetes patients with and without retinopathy

Cardoso, Jéssica F. et al.

Bras. Patol. Med. Lab., Feb 2017, vol.53, no.1, p.31-37

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442017000100031&lng=pt&nrm=iso&tlng=en

■ Influence of the epiretinal membrane on ranibizumab therapy outcomes in patients with diabetic macular edema

Ercalik, Nimet Yesim et al.

Arq. Bras. Oftalmol., Dec 2016, vol.79, no.6, p.373-37

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492016000600373&lng=en&nrm=iso&tlng=en

■ Corneal backscatter in insulin-dependent and non-insulin-dependent diabetes mellitus patients: a pilot study

Calvo-Maroto, Ana M et al.

Arq. Bras. Oftalmol., June 2017, vol.80, no.3, p.148-153

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492017000300148&lng=en&nrm=iso

■ Comparison between multi-spot laser and conventional laser in treatment of diabetic clinically significant macular edema

Elsawah, Kareem Mohsen et al.

Rev. bras.oftalmol., Aug 2017, vol.76, no.4, p.175-180

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802017000400175&lng=en&nrm=iso&tlng=en

■ Fatores de risco associados à intervenção com injeção intravítrea de anti-VEGF em pacientes com edema macular diabético

Faria, Aline Roseane Queiroz de Paiva, Lima Neto, Eufrasio de Andrade and Silva, Cesar Cavalcanti da

Rev. bras.oftalmol., Jun 2017, vol.76, no.3, p.121-127

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802017000300121&lng=en&nrm=iso

■ Actualización de la retinopatia diabética para médicos de atención primaria: hacia uma mejora de la medicina telemátic

J E Muñoz de Escalona-Rojas, A Quereda-Castañeda, O García-Garcia

Semergen 2016;42:172-6

http://www.elsevier.es/es-revista-semergen-medicina-familia-40-articulo-actualizacion-retinopatia-diabetica-medicos-atencion-S1138359315002488

■ Early diagnosis of diabetic retinopathy in primary care.

Jiménez-Báezez, Maria Valeria et al.

Colomb. Med., Mar 2015, vol.46, no.1, p.14-18

http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S1657-95342015000100004&lng=en&nrm=iso

■ by Dr Paulo Fernando Leite

Cardiologia – Centro Médico Unimed BH

Rua Gonçalves Dias 202

Belo Horizonte/MG/Brasil

31 30033306 / 40204020

CRMMG: 7026

Email: pfleite1873@gmail.com

Miastenia Gravis Online (Myasthenia gravis)

Por Paulo Leite 24/10/2017

■ Autoimmune thyroiditis and myasthenia gravis

Angela Lopomo, Sonia Berrih-Aknin

Front Endocrinol (Lausanne) 2017; vol 8: 169

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508005/

■ Thymectomy for myasthenia gravis: What´s next?

M de Perrot, L Donahoe

J Thorac Dis 2017, vol 9 (2): 237-239

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334076/

■ Thymectomy in myasthenia gravis

Yener Aydin, Ali Bilal Ulas, Vahit Mutlu, Abdurrahim Colak, Atilla Eroglu

Eurasian J Med. 2017 ,vol 49(1): 48–52

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389494/

■ Randomized Trial of thymectomy in myasthenia gravis

G.I. Wolfe, H.J. Kaminski, I.B. Aban et al

N Engl J Med. 2016 Aug 11; 375(6): 511–522

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189669/

■ Rare association of celiac disease with myasthenia gravis in a patient with other immune disorders: a Case Report.

Almeida-Menezes, Marcela de et al.

Rev. esp. enferm. dig., Sept 2016, vol.108, no.9, p.586-588

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082016000900015&lng=en&nrm=iso

■ Acute exacerbation of myasthenia gravis with topicalimiquimod use

Saadeddine Saad, Bobbak Mansouri, Chad Housewright

Proc (Bayl Univ Med Cent) 2017 Jul; 30(3): 333.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468034/

■ Single-fiber electromyography in the orbiculareis oculi muscle in patient with ocular myasthenia gravis symptoms: does abnormal jitter predict response to treatment?

Goran Rakocevic, Mark Moster, Mary Kay Floeter

BMC Neurol. 2017; 17: 108

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463377/

■ Tracheoesophageal fistula caused by tracheostomy in a patient with myasthenia gravis after a myasthenia crisis

Chen Jiaxin, Li Jingjing, Zhu Kai, Zhou Zhou, Liu Weibin, Wang Haiyan, Feng Huiyu

Front Neurol. 2017; 8: 217.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437160/

■ Quantitative Myasthenia Gravis Score: a Brazilian multicenter study for translation, cultural adaptation and validation

Oliveira, Ezequiel Fernandes et al.

Arq. Neuro-Psiquiatr., July 2017, vol.75, no.7, p.457-463

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017000700457&lng=en&nrm=iso&tlng=en

■ Brazilian-Portuguese translation, cross-cultural adaptation and validation of the Myasthenia Gravis Composite scale. A multicentric study

Oliveira, Ezequiel Fernandes et al.

Arq. Neuro-Psiquiatr., Nov 2016, vol.74, no.11, p.914-920

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2016001100914&lng=en&nrm=iso

■ Implicações anestésicas na miastenia gravis – revisão da literatura

M F Medeiros, M V Nunes, L G T dos Santos, R B Ravaiane

Revista Médica de Minas Gerais 2016, vol 26 (suppl 1)

http://www.rmmg.org/artigo/detalhes/1937

■ Labour market participation and sick leave among patients diagnosed with myasthenia gravis in Denmark 1927-2011: a Danish nationwide cohort study

Asger Frost, Marie Louise Svendsen, Jes Rahbek et al

BMC Neurol. 2016; 16: 224

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114816/

■ Anti´-musk positive myasthenia gravis and three semiological cardinal signs

André P.C. Matta, Ana C. Andorinho F. Ferreira, Arielle Kirmse et al

Neurol Int. 2016 Nov 2; 8(4): 636

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226044/

■ Regulatory B cells in seropositive myasthenia gravis versus healthy controls

Md Rezaul Karim, Hong-Yan Zhang, Jiang Yuan, Qiang Sun, Yun-Fu Wang

Front Neurol. 2017; 8: 43

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317198/

■ Non-neuronal cholinergic activity is potentiated in myasthenia gravis

Bin Han, Chao Zhang, Shoufeng Liu, Yiping Xia, et al

BMC Neurol. 2017; 17: 28

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299729/

■ Clinical predictors for the prognosis of myasthenia gravis

Lili Wang, Yun Zhang, Maolin He

BMC Neurol. 2017; 17: 77.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395963/

■ Myasthenia gravis: a clinical-immunological update

S Binks, A Vincent, J Palace

Journal of Neurology 2016, vol 263 (4): 826-834

https://link.springer.com/article/10.1007/s00415-015-7963-5

■ Current treatment, emerging translational therapies, and new therapeutics target for autoimmune myasthenia gravis

Jeffrey T. Guptill, Madhu Soni, Matthew N. Meriggioli

Neurotherapeutics. 2016 Jan; 13(1): 118–13

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720661/

■ New diagnosis myasthenia gravis and preeclampsia in late pregnancy

John Ozcan, Ian Frank Balson, Alicia T Dennis

BMJ Case Rep. 2015; 2015: bcr2014208323

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342656/

■ Complicating autoimmune diseases in myasthenia gravis: a review

A Nacu, J B Andersen, V Lisnic et al

Autoimmunity 2015, vol 48 (6): 362-368

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616023/

■ Guidelines for the treatment of ocular myasthenia

EFNS/ENS

E Kerty, A Elsais, Z Argoy et al

European Journal of Neurology 2014, vol 21 (5): 687-693

http://onlinelibrary.wiley.com/doi/10.1111/ene.12359/full

■ Myasthenia gravis: an update for the clinician

J P Sieb

Clin Exp Immunol 2014, vol 175 (3): 408-418

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927901/

■ Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study

J B Andersen, J F Owe, A Engeland et al

European Journal of Neurology 2014, vol 21 (7): 948-955

http://onlinelibrary.wiley.com/doi/10.1111/ene.12439/full

■ Severe preeclampsia in the setting of myasthenia gravis

Adam J. Lake, Antoun Al Khabbaz, Renée Keeney

Case Rep Obstet Gynecol. 2017; 2017: 9204930

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322431/

■ Pyridostigmine induced prolonged asystole in a patient with myasthenia gravis successfully treated with hyoscyamine

M S Khan, A Tiwari, Z Khan et al

Case Reports in Cardiology 2017 (2017), Article ID 6956298, 4 pages

https://www.hindawi.com/journals/cric/2017/6956298/